Sirt1 activator (233% at 10 µM)1 Suppresses TNFalpha release from THP-1 cells and stimulates adipogenesis in 3T3L1 cells1. SIRT1 stimulation by SirtAct leads to decreased tissue factor mediated thrombogenicity in mice2. Inhibits NFkappaB activation and reduces inflammatory cytokine production in lamina propria mononuclear cells from IBD patients3. Prevents and cures experimental colitis in a mouse model3.
* VAT and and shipping costs not included. Errors and price changes excepted